INTRODUCTION spergillosis of the paranasal sinuses and orbit
Ausual ly is self-limiting with a good prognosis. In contrast, invasive diseases may result in significant morbidity and mortality from intra-orbital and intracranial extension. Invasive disease occurs in debilitated patients with decreased immunity such as diabetes mellitus, Human Immunodeficiency Virus, 1, 2, 3 cytotoxic drugs users, etc. Intracranial extension often results in mortality despite therapy. Nonetheless, invasive sino-orbital aspergillosis may occur in immunocompetent patients resulting in significant morbidity and mortality. The standard treatment for invasive sino-orbital diseases has been radical surgical intervention, including orbital exenteration, sinus excision, and aggressive intracranial debridement. However more recently, poor prognosis have been reported with a combination of limited surgical debridement and anti-fungal therapy particularly in immunocompetent patients due to late presentation to health care facility. We present a case of invasive sinoorbital aspergillosis with extension into the dura c o m p l i c a t e d b y c h e e s y c o l l e c t i o n i n a n immunocompetent patient. The patient was successfully managed with surgical debridement and anti-fungal chemotherapy.
Case report: history and examination
A 38 year old female who had gross total resection of fronto-orbital lesion, with intracranial extension for about 3 years prior to presentation. However, she started having serous discharge from the operation site about one year after the surgery with associated proptosis of the left eye. There was no discharge from the nose, ear or contralateral eye. Her medical history included only hypertension. The patient had marked proptosis, limitation of extra ocular motility, ptosis, and a large discharging (left) supra orbital sinus. The patient is immunocompetent as revealed by nonreactive retroviral screening test. The other findings from the physical examination were not significant. The patient was admitted a n d r e v i e w e d b y b o t h N e u r o s u r g e r y a n d t h e Otorynolaryngology team, and a computer tomography scan of the brain was performed prior to surgery.
Hospital care
The imaging study of the patient's brain showed a left frontoorbital uniformly contrast-enhancing extra-axial lesion with thickened peripheral capsule. (fig1a,1b,1c) There was an associated left fronto-orbital skull defect and thickening of the left maxillary sinus mucosa and calcifications. A thorough medical examination and review of patient, including Human Immunodeficiency Virus screening, did not reveal evidence of immunodeficiency disorder or systemic fungal infection. Given the immunocompetence of the patient, chronic nature of the disease, clinical and radiologic findings, a diagnosis of Recurrent fronto-ethmoidal mucocoele with fistula was made and the patient was prepared for external frontoethmoidectomy. Intraoperatively, a left fronto-cutaneous fistula was seen, cheesy material with frontal sinus with extension to the dura as well as reactive dura was observed. The cheesy material was evacuated and sent to the laboratory, irrigation was carried out and haemostasis secured with electrocautery. A frontonasal stent was placed for two weeks to allow for epithelization and enhanced drainage from the frontal sinus to the nasal cavity to allow for healing of the fronto-cutaneous fistula.
Microbiology and molecular examination
Cultures of the cheesy material sample obtained were consistent with Aspergillus species (figure 2). Internal transcribed spacer (ITS) region gene sequencing was performed to reliably identify the organism. The universal primers for fungi F(5'-TCCGTAGGTGAACCTGCGG-3') and R(5'-TCCTCCGCTTATTGATATGC-3') was used and generating a sequence which on BLAST analysis matched Aspergillus aculeatus (GenBank accession number MN187974.1) was identified. Due to unavailability of antifungal drugs, patient was commenced empirically on intravenous fluconazole for two weeks and discharged home on oral voriconazole (300mg) twice daily. The patient is eight months post-surgery doing very great. 
DISCUSSION
Invasive sino-orbital aspergillosis is seen usually in immunodeficient patients and result in morbidity and mortality; it is rare in immunocompetent patients. Making a diagnosis of invasive sino-orbital aspergillosis in patients can be challenging particularly in low and middle income countries. Our patient had a chronic progression of lesion similarto findings by Sivak-Callcot and colleagues who reported a delay in diagnosis of up to 10 months because of nonspecific complaints of retro-orbital pain prior to ophthalmic features.
Several reports from previous studies showed that patients initially present with persistent unilateral, severe, frontal headache, or retro-orbital pain as their main presenting 4, 5, 6 complaints. Some of the patients were diagnosed with temporal arteritis or orbital pseudo tumour and were treated 7, 8, 9, 10 with high dose systemic corticosteroids. Therefore, even in healthy patients, a complaint of persistent and/or escalating retro-orbital pain with or without discharging orbital sinus and/or ophthalmic features should prompt physicians to request orbital and cranial imaging studies before making a diagnosis and instituting treatment. Because the orbital findings are often non-specific, clinicians should have a high index of suspicion. Computed tomography scan findings of paranasal sinus and orbital mass and/or bone destruction (with or without optic nerve involvement) should be investigated by a biopsy to rule out fungal infection. The pathophysiology of invasive aspergillosis in immunocompetent patients is not clear. It is believed that predisposing factors for both invasive and noninvasive types of infections include mechanical obstruction of nose and paranasal sinuses, such as septal abnormalities, orbital infections, and nasal polyps. The risk factor in our patient is orbital infection. Intracranial spread of fungus via bone erosion and migration along the blood vessels has been 11, 8 documented in previous studies. It is possible that the discharging orbital sinus was responsible for the infection and spread. Perhaps, early treatment with antifungal agent based on clinical and radiologic finding prior to surgery may reduce morbidity and mortality. Management of invasive sino-orbital Aspergillosis in immunocompetent patients remains controversial. Management modality ranges from medical management 12, 13 alone to radical surgery with adjuvant chemotherapy. Combination of antifungal agents has been used successfully 14, 15 to control infection in some studies. Voriconazole is the drug of choice for invasive aspergillosis because patients demonstrate better tolerance for it and because of its lower toxicity compared to amphotericin B. Our patient had radical surgery with debridement followed with available parenteral fluconazole and then oral voriconazole to successfully control the disease. Due to the high rates of morbidity and mortality following radical debridement of invasive fungal infection, we believe that a combination of both surgery and medical chemotherapy may be reasonable in immunocompetent patients. 
